Chair-Integrated Foam Modifications in Coccydynia
Ergonomic Effects of Material- and Geometry-Modified, Chair-Integrated Foams on Pressure Distribution, Pain, and Sitting Comfort in Individuals With Coccydynia
1 other identifier
interventional
42
1 country
1
Brief Summary
The aim of this study is to evaluate the effects of chairs with different ergonomic designs on quality of life, discomfort, and pain in individuals with coccydynia (tailbone pain).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 16, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
Study Completion
Last participant's last visit for all outcomes
June 15, 2026
April 16, 2026
April 1, 2026
1 month
April 10, 2026
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pressure Distribution Measurement (Load Cell-Equipped Chair System)
Assessment of sitting pressure distribution across right, left, and central regions in kilograms using a custom-designed load cell-integrated chair.
Baseline + 1 week
Paris Questionnaire
Evaluation of pain and functional status associated with coccydynia.
Baseline + 1 week
Secondary Outcomes (2)
Extended Nordic Musculoskeletal Questionnaire (NMQ-E)
Baseline + 1 week
EuroQol Quality of Life Scale (EQ-5D-3L)
Baseline + 1 week
Study Arms (6)
Group 1: Chair with Foam Type A
EXPERIMENTALParticipants will use ergonomically modified chair A with different foam properties during their working hours.
Group 2: Chair with Foam Type B
EXPERIMENTALParticipants will use ergonomically modified chair B with different foam properties during their working hours.
Group 3: Chair with Foam Type C
EXPERIMENTALParticipants will use ergonomically modified chair C with different foam properties during their working hours.
Group 4: Chair with Foam Type D
EXPERIMENTALParticipants will use ergonomically modified chair D with different foam properties during their working hours.
Group 5: Chair with Foam Type E
EXPERIMENTALParticipants will use ergonomically modified chair E with different foam properties during their working hours.
Group 6: Chair with Foam Type F
EXPERIMENTALParticipants will use ergonomically modified chair F with different foam properties during their working hours.
Interventions
Participants will use ergonomically modified chairs with different foam properties during their working hours.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 65 years
- Working at a desk for at least 5-6 hours per day
- Experiencing coccydynia (tailbone pain)
- Able to sit independently without assistive support
- No diagnosed spinal disorders (e.g., lumbar disc herniation)
- Willing to use the assigned chair during working hours for 1 week
- Able to understand and complete questionnaires
- Provided written informed consent
You may not qualify if:
- History of spinal surgery
- Diagnosed spinal disorders (e.g., lumbar disc herniation, scoliosis, severe degenerative spine disease)
- Neurological disorders affecting posture, sitting balance, or sensation
- Severe musculoskeletal conditions (e.g., hip or pelvic disorders) that may affect sitting
- Pregnancy
- Inability to sit for prolonged periods
- Use of assistive seating devices (e.g., orthopedic cushions) during the study period
- Regular use of pain medication that may affect outcome measures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kto Karatay University
Konya, 42030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2026
First Posted
April 16, 2026
Study Start (Estimated)
May 1, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 15, 2026
Last Updated
April 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy and confidentiality considerations.